Utilizing Fibrosis-4 score to assess risk for hepatic fibrosis in patients with psoriasis on methotrexate.
作者信息
Yim Elizabeth, Deutsch Alana, Nazarian Roya S, McLellan Beth N, Espinoza Danielle, Wolkoff Allan W, Cohen Steven R
机构信息
Division of Dermatology, University of California, Los Angeles, CA, USA.
Division of Dermatology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
出版信息
Int J Dermatol. 2021 Mar;60(3):e100-e101. doi: 10.1111/ijd.15201. Epub 2020 Sep 29.
PMID:32989752
Abstract
摘要
相似文献
1
Utilizing Fibrosis-4 score to assess risk for hepatic fibrosis in patients with psoriasis on methotrexate.
Int J Dermatol. 2021 Mar;60(3):e100-e101. doi: 10.1111/ijd.15201. Epub 2020 Sep 29.
2
Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.甲氨蝶呤治疗银屑病的并发症，特别提及肝纤维化
J Invest Dermatol. 1982 Oct;79(4):229-32. doi: 10.1111/1523-1747.ep12500067.
3
Methotrexate therapy for psoriasis. Guideline revisions.甲氨蝶呤治疗银屑病。指南修订版。
Arch Dermatol. 1973 Jul;108(1):35.
4
Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.接受甲氨蝶呤治疗的银屑病患者的血清III型前胶原肽、动态肝功能试验与肝纤维化
Br J Dermatol. 1990 Jan;122(1):1-7. doi: 10.1111/j.1365-2133.1990.tb08232.x.
5
Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?磁共振弹性成像和瞬时弹性成像作为肝纤维化的非侵入性分析方法：它们能否消除接受甲氨蝶呤治疗的银屑病患者进行肝活检的必要性？
Int J Dermatol. 2015 Jul;54(7):752-6. doi: 10.1111/ijd.12923.
6
Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?监测银屑病患者中氨甲蝶呤诱导的肝纤维化：连续肝活检是否合理？
Aliment Pharmacol Ther. 2004 Feb 15;19(4):391-9. doi: 10.1046/j.1365-2036.2004.01819.x.
7
The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.阿维A与甲氨蝶呤联合治疗寻常型银屑病疗效更高且肝纤维化更少。
Pharmacol Res. 2017 Jul;121:158-168. doi: 10.1016/j.phrs.2017.04.014. Epub 2017 Apr 13.
8
Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.长期接受高累积剂量甲氨蝶呤治疗的银屑病和银屑病关节炎患者的肝纤维化
Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.
9
Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.银屑病患者的半乳糖耐量试验及甲氨蝶呤诱导的肝纤维化和肝硬化
Acta Derm Venereol. 1982;62(5):448-9.
10
Fulminant hepatic failure after methotrexate and PUVA therapy for psoriasis.甲氨蝶呤和补骨脂素紫外线A光化学疗法治疗银屑病后出现暴发性肝衰竭。
J Clin Gastroenterol. 1993 Dec;17(4):311-3. doi: 10.1097/00004836-199312000-00010.
引用本文的文献
1
Unveiling the impact of psoriasis on liver health: does methotrexate play a villainous role?揭示银屑病对肝脏健康的影响：甲氨蝶呤是否扮演了有害角色？
Arch Dermatol Res. 2024 Jun 28;316(7):437. doi: 10.1007/s00403-024-03193-9.
2
Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis.银屑病患者肝纤维化的患病率及危险因素：一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 Dec 15;9:1068157. doi: 10.3389/fmed.2022.1068157. eCollection 2022.
Zotero 插件